NVAX peer analysis
Novavax (NVAX) against its competitors: price, today's move, 1-year return and market value side by side.
NVAX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARCT Arcturus | $11.03 | -9.22% | 14.54% | $313.51M |
| BNTX BioNTech | $87.49 | -0.77% | -16.41% | $22.15B |
| EBS Emergent BioSolutions | $6.81 | -5.68% | -46.96% | $349.17M |
| GOVX GeoVax Labs | $0.17 | -9.31% | -98.80% | – |
| INO Inovio | $1.90 | 215.41% | -19.49% | $62.29M |
| MRNA Moderna | $220.62 | -0.49% | 684.03% | $88.52B |
| OGEN Oragenics | $0.37 | -0.05% | -71.23% | $1.69M |
| PCVX Vaxcyte | $60.62 | -2.27% | 35.46% | $9.76B |
| SCNI Scinai Immunotherapeutics | $0.47 | -9.05% | -96.75% | – |
| VALN Valneva | $5.45 | -4.55% | -40.24% | – |
| NVAX Novavax | $9.54 | -5.36% | 13.17% | $1.66B |
- NVAX's peers: ARCT (Arcturus), BNTX (BioNTech), EBS (Emergent BioSolutions), GOVX (GeoVax Labs), INO (Inovio), MRNA (Moderna), OGEN (Oragenics), PCVX (Vaxcyte).
Updated 2026-11-02 23:14 UTC